Naassila M, Pierrefiche O, Ledent C, Daoust M (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46: 243-253

Nackley AG, Makriyannis A, Hohmann AG (2003) Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 119: 747-757

Nackley AG, Suplita RL, Hohmann AG (2003) A peripheral cannabinoid mechanism suppresses spinal Fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 117: 659-670

Nadipuram AK, Krishnamurthy M, Ferreira AM, Li W, Moore BM (2003) Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors. Bioorg Med Chem 11: 3121-3132

Nagai K, Oubridge C, Kuglstatter A, Menichelli E, Isel C, Jovine L (2003) Structure, function and evolution of the signal recognition particle. Embo J 22: 3479-3485

Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19: 2987-2995

Nagendra HG, Harrington AE, Harmer NJ, Pellegrini L, Blundell TL, Burke DF (2001) Sequence analyses and comparative modeling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution. FEBS Lett 501: 51-58

Nagy P, Jenei A, Kirsch AK, Szollosi J, Damjanovich S, Jovin TM (1999) Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy. J Cell Sci 112 (Pt 11): 1733-1741

Nakagawa Y, Waku K (1988) Selective inhibition of free arachidonic acid production in activated alveolar macrophages by calmodulin antagonists. Biochem Biophys Res Commun 156: 947-953

Nakamura A, Shiomi H (1999) Recent advances in neuropharmacology of cutaneous nociceptors. Jpn J Pharmacol 79: 427-431

Nakane S, Oka S, Arai S, Waku K, Ishima Y, Tokumura A, Sugiura T (2002) 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. Arch Biochem Biophys 402: 51-58

Nakane S, Tanaka T, Satouchi K, Kobayashi Y, Waku K, Sugiura T (2000) Occurrence of a novel cannabimimetic molecule 2-sciadonoylglycerol (2-eicosa-5',11',14'-trienoylglycerol) in the umbrella pine Sciadopitys verticillata seeds. Biol Pharm Bull 23: 758-761

Nakatsuka T, Chen HX, Roper SN, Gu JG (2003) Cannabinoid receptor-1 activation suppresses inhibitory synaptic activity in human dentate gyrus. Neuropharmacology 45: 116-121

Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E (2000) Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol 361: 19-24

Natarajan V, Reddy PV, Schmid PC, Schmid HH (1981) On the biosynthesis and metabolism of N-acylethanolamine phospholipids in infarcted dog heart. Biochim Biophys Acta 664: 445-448

Natarajan V, Reddy PV, Schmid PC, Schmid HH (1982) N-Acylation of ethanolamine phospholipids in canine myocardium. Biochim Biophys Acta 712: 342-355

Natarajan V, Schmid PC, Reddy PV, Schmid HH (1984) Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J Neurochem 42: 1613-1619

Natarajan V, Schmid PC, Reddy PV, Zuzarte-Augustin ML, Schmid HH (1983) Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations. J Neurochem 41: 1303-1312

Natarajan V, Schmid PC, Reddy PV, Zuzarte-Augustin ML, Schmid HH (1985) Occurrence of N-acylethanolamine phospholipids in fish brain and spinal cord. Biochim Biophys Acta 835: 426-433

Natarajan V, Schmid PC, Schmid HH (1986) N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain. Biochim Biophys Acta 878: 32-41

Nathanson MH, Fallon MB, Padfield PJ, Maranto AR (1994) Localization of the type 3 inositol 1,4,5-trisphosphate receptor in the Ca2+ wave trigger zone of pancreatic acinar cells. J Biol Chem 269: 4693-4696

Navarro L, Martinez-vargas M, Murillo-rodriguez E, Landa A, Mendez-diaz M, Prospero-garcia O (2003) Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound. Neuroscience 120: 855-859

Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado R, Koob GF, Rodriguez de Fonseca F (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21: 5344-5350

Navarro M, Chowen J, Rocio ACM, del Arco I, Villanua MA, Martin Y, Roberts AJ, Koob GF, de Fonseca FR (1998) CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. Neuroreport 9: 3397-3402

Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, Rodriguez de Fonseca F (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8: 491-496

Navarro M, Rodriguez de Fonseca F (1998) The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease. Neurobiol Dis 5: 379-385

Naver B, Stub C, Moller M, Fenger K, Hansen AK, Hasholt L, Sorensen SA (2003) Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse. Neuroscience 122: 1049-1057

Nawy S (2000) Regulation of the on bipolar cell mGluR6 pathway by Ca2+. J Neurosci 20: 4471-4479

Needleman DH, Aghdasi B, Seryshev AB, Schroepfer GJ, Jr., Hamilton SL (1997) Modulation of skeletal muscle Ca2(+)-release channel activity by sphingosine. Am J Physiol 272: C1465-1474

Nelson TE, Lin M, Zapata-Sudo G, Sudo RT (1996) Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications. Anesthesiology 84: 1368-1379

Nemeth J, Helyes Z, Than M, Jakab B, Pinter E, Szolcsanyi J (2003) Concentration-dependent dual effect of anandamide on sensory neuropeptide release from isolated rat tracheae. Neurosci Lett 336: 89-92

Nerli B, Romanini D, Pico G (1997) Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin. Chem Biol Interact 104: 179-202

Nerou EP, Riley AM, Potter BV, Taylor CW (2001) Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor. Biochem J 355: 59-69

Nethrapalli IS, Singh M, Guan X, Guo Q, Lubahn DB, Korach KS, Toran-Allerand CD (2001) Estradiol (E2) elicits SRC phosphorylation in the mouse neocortex: the initial event in E2 activation of the MAPK cascade? Endocrinology 142: 5145-5148

Netsiri C, Bradley DP, Takeda T, Smith MI, Papadakis N, Hall LD, Parsons AA, James MF, Huang CL (2003) A delayed class of BOLD waveforms associated with spreading depression in the feline cerebral cortex can be detected and characterised using independent component analysis (ICA). Magn Reson Imaging 21: 1097-1110

Neubert TA, Johnson RS, Hurley JB, Walsh KA (1992) The rod transducin alpha subunit amino terminus is heterogeneously fatty acylated. J Biol Chem 267: 18274-18277

New DC, Wong YH (2003) BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates. FEBS Lett 536: 157-160

Newman EA, Zahs KR (1997) Calcium waves in retinal glial cells. Science 275: 844-847

Newman JL, Stiers DL, Anderson WH, Schmid HH (1986) Phase behavior of synthetic N-acylethanolamine phospholipids. Chem Phys Lipids 42: 249-260

Newsham-West D, Darlington CL, Smith PF (1998) Potent effects of a selective cannabinoid receptor agonist on some guinea pig medial vestibular nucleus neurons. Eur J Pharmacol 348: R1-2

Neyton J, Trautmann A (1986) Acetylcholine modulation of the conductance of intercellular junctions between rat lacrimal cells. J Physiol 377: 283-295

Ng EW, Aung MM, Abood ME, Martin BR, Razdan RK (1999) Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. J Med Chem 42: 1975-1981

Ng YF, Meillon JC, Ryan T, Dominey AP, Davis AP, Sanders JK (2001) Gel-Phase MAS NMR Spectroscopy of a Polymer-Supported Pseudorotaxane and Rotaxane: Receptor Binding to an "Inert" Polyethylene Glycol Spacer We thank the EPSRC and Enterprise Ireland as well as the EU TMR programme for financial support. Angew Chem Int Ed Engl 40: 1757-1760

Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF (2004) Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult Scler 10: 158-164

Nicholas RS, Wing MG, Compston A (2001) Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa B. Eur J Neurosci 13: 959-967

Nichols BJ (2003) GM1-containing lipid rafts are depleted within clathrin-coated pits. Curr Biol 13: 686-690

Nichols BJ, Pelham HR (1998) SNAREs and membrane fusion in the Golgi apparatus. Biochim Biophys Acta 1404: 9-31

Nicholson R, Small J, Dixon AK, Spanswick D, Lee K (2003) Serotonin receptor mRNA expression in rat dorsal root ganglion neurons. Neurosci Lett 337: 119-122

Nicholson RA, Liao C, Zheng J, David LS, Coyne L, Errington AC, Singh G, Lees G (2003) Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res 978: 194-204

Nie J, Lewis DL (2001) The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling. Neuroscience 107: 161-167

Nie J, Lewis DL (2001) Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration. J Neurosci 21: 8758-8764

Niederhoffer N, Hansen HH, Fernandez-Ruiz JJ, Szabo B (2001) Effects of cannabinoids on adrenaline release from adrenal medullary cells. Br J Pharmacol 134: 1319-1327

Niederhoffer N, Schmid K, Szabo B (2003) The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Naunyn Schmiedebergs Arch Pharmacol 367: 434-443

Niederhoffer N, Szabo B (1999) Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126: 457-466

Niederhoffer N, Szabo B (1999) Involvement of CB1 cannabinoid receptors in the EDHF-dependent vasorelaxation in rabbits. Br J Pharmacol 126: 1383-1386

Nieri P, Greco R, Adinolfi B, Breschi MC, Martinotti E, Nannetti C, Podesta A (2003) CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes. Naunyn Schmiedebergs Arch Pharmacol 368: 352-359

Nieri P, Martinotti E, Testai L, Adinolfi B, Calderone V, Breschi MC (2003) R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors. Eur J Pharmacol 459: 75-81

Nieri P, Martinotti E, Testai L, Martinelli C, Breschi MC (2003) Effects of cannabinoids on non-adrenergic non-cholinergic-mediated relaxation in guinea-pig trachea. Eur J Pharmacol 475: 115-118

Nieuwenhuizen WF, van Leeuwen S, Jack RW, Egmond MR, Gotz F (2003) Molecular cloning and characterization of the alkaline ceramidase from Pseudomonas aeruginosa PA01. Protein Expr Purif 30: 94-104

Nilius B, Vriens J, Prenen J, Droogmans G, Voets T (2004) TRPV4 calcium entry channel: a paradigm for gating diversity. Am J Physiol Cell Physiol 286: C195-205

Nilsson O, Jacobsson SO, Fowler CJ (2003) Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. Comp Biochem Physiol C Toxicol Pharmacol 136: 245-251

Nirodi CS, Crews BC, Kozak KR, Morrow JD, Marnett LJ (2004) The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells. Proc Natl Acad Sci U S A 101: 1840-1845

Nirodi CS, Crews BC, Kozak KR, Morrow JD, Marnett LJ (2004) The glyceryl ester of prostaglandin E-2 mobilizes calcium and activates signal transduction in RAW264.7 cells. Proceedings of the National Academy of Sciences of the United States of America 101: 1840-1845

Niven JE, Burrows M (2003) Spike width reduction modifies the dynamics of short-term depression at a central synapse in the locust. J Neurosci 23: 7461-7469

Niven JE, Vahasoyrinki M, Juusola M, French AS (2004) Interactions between light-induced currents, voltage-gated currents, and input signal properties in Drosophila photoreceptors. J Neurophysiol 91: 2696-2706

Nocerino E, Amato M, Izzo AA (2000) Cannabis and cannabinoid receptors. Fitoterapia 71 Suppl 1: S6-12

Noe SN, Newton C, Widen R, Friedman H, Klein TW (2000) Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes. J Neuroimmunol 110: 161-167

Noe SN, Newton C, Widen R, Friedman H, Klein TW (2001) Modulation of CB1 mRNA upon activation of murine splenocytes. Adv Exp Med Biol 493: 215-221

Noe SN, Nyland SB, Ugen K, Friedman H, Klein TW (1998) Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN. Adv Exp Med Biol 437: 223-229

Nogueron MI, Porgilsson B, Schneider WE, Stucky CL, Hillard CJ (2001) Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. J Neurochem 79: 371-381

Nong L, Newton C, Cheng Q, Friedman H, Roth MD, Klein TW (2002) Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. J Neuroimmunol 127: 169-176

Nong L, Newton C, Friedman H, Klein TW (2001) CB1 and CB2 receptor mRNA expression in human peripheral blood mononuclear cells (PBMC) from various donor types. Adv Exp Med Biol 493: 229-233

Nowell KW, Pettit DA, Cabral WA, Zimmerman HW, Jr., Abood ME, Cabral GA (1998) High-level expression of the human CB2 cannabinoid receptor using a baculovirus system. Biochem Pharmacol 55: 1893-1905

Nugent C, Prins JB, Whitehead JP, Savage D, Wentworth JM, Chatterjee VK, O'Rahilly S (2001) Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol Endocrinol 15: 1729-1738

Nugent C, Prins JB, Whitehead JP, Wentworth JM, Chatterjee VK, O'Rahilly S (2001) Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma. J Biol Chem 276: 9149-9157

Nutt SL, Dingwell KS, Holt CE, Amaya E (2001) Xenopus Sprouty2 inhibits FGF-mediated gastrulation movements but does not affect mesoderm induction and patterning. Genes Dev 15: 1152-1166

O'Kane CJ, Asztalos Z (1999) Sexual behaviour: Courting dissatisfaction. Curr Biol 9: R289-292

O'Keefe TL, Williams GT, Batista FD, Neuberger MS (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189: 1307-1313

O'Keefe TL, Williams GT, Davies SL, Neuberger MS (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274: 798-801

O'Keefe TL, Williams GT, Davies SL, Neuberger MS (1998) Mice carrying a CD20 gene disruption. Immunogenetics 48: 125-132

O'Rahilly S, Farooqi IS, Yeo GS, Challis BG (2003) Minireview: human obesity-lessons from monogenic disorders. Endocrinology 144: 3757-3764

O'Rourke L, Tooze R, Fearon DT (1997) Co-receptors of B lymphocytes. Curr Opin Immunol 9: 324-329

O'Sullivan NL, Montgomery PC (1990) Selective interactions of lymphocytes with neonatal and adult lacrimal gland tissues. Invest Ophthalmol Vis Sci 31: 1615-1622

O'Sullivan NL, Raja R, Montgomery PC (1995) Lymphocyte adhesive interactions with lacrimal gland acinar epithelial cells in primary culture. Invest Ophthalmol Vis Sci 36: 2246-2253

O'Sullivan SE, Kendall DA, Randall MD (2004) Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA). Br J Pharmacol 141: 803-812

Oba T (1997) Niflumic acid differentially modulates two types of skeletal ryanodine-sensitive Ca(2+)-release channels. Am J Physiol 273: C1588-1595

Oba T, Ishikawa T, Murayama T, Ogawa Y, Yamaguchi M (2000) H(2)O(2) and ethanol act synergistically to gate ryanodine receptor/calcium-release channel. Am J Physiol Cell Physiol 279: C1366-1374

Obata T, Sakurai Y, Kase Y, Tanifuji Y, Horiguchi T (2003) Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2alpha) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples. J Chromatogr B Analyt Technol Biomed Life Sci 792: 131-140

Ofek I, Fogel M, Attar-Namdar M, Tam Y, Muller R, Mechoulam R, Shohami E, Bab I (2003) Endocannabinoid regulation of bone remodeling. Journal of Bone and Mineral Research 18: S69-S69

Offertaler L, Mo FM, Batkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G (2003) Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63: 699-705

Ogilvy-Stuart AL, Soos MA, Hands SJ, Anthony MY, Dunger DB, O'Rahilly S (2001) Hypoglycemia and resistance to ketoacidosis in a subject without functional insulin receptors. J Clin Endocrinol Metab 86: 3319-3326

Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo MM, Manabe T, Kano M (2003) Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 18: 109-116

Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo MM, Manabe T, Kano M (2003) Postsynaptic M-1 and M-3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. European Journal of Neuroscience 18: 109-116

Ohno-Shosaku T, Shosaku J, Tsubokawa H, Kano M (2002) Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur J Neurosci 15: 953-961

Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N, Zimmer A, Kano M (2002) Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci 22: 3864-3872

Oka S, Tsuchie A, Tokumura A, Muramatsu M, Suhara Y, Takayama H, Waku K, Sugiura T (2003) Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J Neurochem 85: 1374-1381

Okamoto H, Yatomi Y, Ohmori T, Satoh K, Matsumoto Y, Ozaki Y (2000) Sphingosine 1-phosphate stimulates G(i)- and Rho-mediated vascular endothelial cell spreading and migration. Thromb Res 99: 259-265

Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279: 5298-5305

Okkenhaug K, Bilancio A, Emery JL, Vanhaesebroeck B (2004) Phosphoinositide 3-kinase in T cell activation and survival. Biochem Soc Trans 32: 332-335

Okkenhaug K, Vanhaesebroeck B (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 3: 317-330

Okubo Y, Siddle K, Firth H, O'Rahilly S, Wilson LC, Willatt L, Fukushima T, Takahashi S, Petry CJ, Saukkonen T, Stanhope R, Dunger DB (2003) Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. J Clin Endocrinol Metab 88: 5981-5988

Olah Z, Karai L, Iadarola MJ (2001) Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem 276: 31163-31170

Olah Z, Karai L, Iadarola MJ (2002) Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways. J Biol Chem 277: 35752-35759

Olah Z, Karai L, Ruda MA, Iadarola MJ (2000) Anandamide induces Ca2+-uptake in DRG neurons and in cells ectopically expressing the vanilloid receptor (VR1). Society for Neuroscience Abstracts 26: Abstract No.-39.36

Oland LD, Davison JS, Sharkey KA (2003) Endocannabinoids Inhibit Emesis in the Ferret. Digestive Disease Week Abstracts and Itinerary Planner 2003

Oliva JM, Ortiz S, Palomo T, Manzanares J (2004) Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain. J Psychopharmacol 18: 59-65

Oliveira L, Stallwood NA, Crankshaw DJ (2000) Effects of some isoprostanes on the human umbilical artery in vitro. Br J Pharmacol 129: 509-514

Oliver D, Lien CC, Soom M, Baukrowitz T, Jonas P, Fakler B (2004) Functional conversion between A-type and delayed rectifier K+ channels by membrane lipids. Science 304: 265-270

Olson JM, Kennedy SJ, Cabral GA (2003) Expression of the murine CB2 cannabinoid receptor using a recombinant Semliki Forest virus. Biochem Pharmacol 65: 1931-1942

Omar R, Bottrill FE, Hiley CR, White R (2000) Interaction of cyclic AMP modulating agents with levcromakalim in the relaxation of rat isolated mesenteric artery. Eur J Pharmacol 401: 85-96

Omeir RL, Arreaza G, Deutsch DG (1999) Identification of two serine residues involved in catalysis by fatty acid amide hydrolase. Biochem Biophys Res Commun 264: 316-320

Omeir RL, Chin S, Hong Y, Ahern DG, Deutsch DG (1995) Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase. Life Sci 56: 1999-2005

Onaivi ES, Akinshola BE, Uhl GR (2001) Modulation of cannabinoid receptor (CB1) mediated effects in-vitro and in-vivo. Society for Neuroscience Abstracts 27

Onaivi ES, Chakrabarti A, Chaudhuri G (1996) Cannabinoid receptor genes. Prog Neurobiol 48: 275-305

Onaivi ES, Chakrabarti A, Gwebu ET, Chaudhuri G (1995) Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice. Behav Brain Res 72: 115-125

Onaivi ES, Chaudhuri G, Abaci AS, Parker M, Manier DH, Martin PR, Hubbard JR (1999) Expression of cannabinoid receptors and their gene transcripts in human blood cells. Prog Neuropsychopharmacol Biol Psychiatry 23: 1063-1077

Onaivi ES, Colas D, Perchuk A, Zhang PW, Ishiguro H, Taylor RE, Uhl GR, Akinshola BE (2003) Interaction between cannabinoids and abused substances. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003

Onaivi ES, Ishiguro H, Zhang P, Akinshola BE, Lin Z, Darmani N, Leonard C, Hall FS, Hope B, Uhl GR (2002) Cannabinoid Genetics and Behavior. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002

Onaivi ES, Leonard CM, Ishiguro H, Zhang PW, Lin Z, Akinshola BE, Uhl GR (2002) Endocannabinoids and cannabinoid receptor genetics. Prog Neurobiol 66: 307-344

Ong WY, Mackie K (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 92: 1177-1191

Ong WY, Mackie K (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. J Neurocytol 28: 39-45

Onizuka S, Kasaba T, Ibusuki S, Takasaki M (2002) Sevoflurane Decreases Intracellular Potassium Concentration and Membrane Potentials in the RPeD1 Neuron of Lymnaea Stagnalis. Anesthesiology Abstracts of Scientific Papers Annual Meeting: Abstract No. A-85

Onley DJ, Knight CG, Tuckwell DS, Barnes MJ, Farndale RW (2000) Micromolar Ca2+ concentrations are essential for Mg2+-dependent binding of collagen by the integrin alpha 2beta 1 in human platelets. J Biol Chem 275: 24560-24564

Onorato JM, Jenkins AJ, Thorpe SR, Baynes JW (2000) Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine. J Biol Chem 275: 21177-21184

Onoue H, Tanaka H, Tanaka K, Doira N, Ito Y (2000) Heterooligomer of type 1 and type 2 inositol 1, 4, 5-trisphosphate receptor expressed in rat liver membrane fraction exists as tetrameric complex. Biochem Biophys Res Commun 267: 928-933

Orliac ML, Peroni R, Celuch SM, Adler-Graschinsky E (2003) Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats. J Pharmacol Exp Ther 304: 179-184

Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V (2003) Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol 65: 1473-1481

Ortiz S, Oliva JM, Perez-Rial S, Palomo T, Manzanares J (2004) Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol 39: 88-92

Otto S (2003) Dynamic combinatorial chemistry: a new method for selection and preparation of synthetic receptors. Curr Opin Drug Discov Devel 6: 509-520

Otto S, Furlan RL, Sanders JK (2002) Recent developments in dynamic combinatorial chemistry. Curr Opin Chem Biol 6: 321-327

Otto S, Kubik S (2003) Dynamic combinatorial optimization of a neutral receptor that binds inorganic anions in aqueous solution. J Am Chem Soc 125: 7804-7805

Oubridge C, Kuglstatter A, Jovine L, Nagai K (2002) Crystal structure of SRP19 in complex with the S domain of SRP RNA and its implication for the assembly of the signal recognition particle. Mol Cell 9: 1251-1261

Ouyang Y, Hwang SG, Han SH, Kaminski NE (1998) Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol Pharmacol 53: 676-683

Owen DJ, Evans PR (1998) A structural explanation for the recognition of tyrosine-based endocytotic signals. Science 282: 1327-1332

Owen DJ, Wigge P, Vallis Y, Moore JD, Evans PR, McMahon HT (1998) Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation. Embo J 17: 5273-5285

Owen VJ, Taske NL, Lamb GD (1997) Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia. Am J Physiol 272: C203-211

Oyamada H, Iino M, Endo M (1993) Effects of ryanodine on the properties of Ca2+ release from the sarcoplasmic reticulum in skinned skeletal muscle fibres of the frog. J Physiol 470: 335-348

Oz M, Ravindran A, Diaz-Ruiz O, Zhang L, Morales M (2003) The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J Pharmacol Exp Ther 306: 1003-1010

Oz M, Tchugunova YB, Dunn SM (2000) Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes. Eur J Pharmacol 404: 13-20

Oz M, Zhang L, Morales M (2002) Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. Synapse 46: 150-156

Oz M, Zhang L, Ravindran A, Morales M, Lupica CL (2004) DIFFERENTIAL EFFECTS OF ENDOGENOUS AND SYNTHETIC CANNABINOIDS ON {alpha}7-NICOTINIC ACETYLCHOLINE RECEPTOR-MEDIATED RESPONSES IN XENOPUS OOCYTES. J Pharmacol Exp Ther

Ozanne SE, Dorling MW, Wang CL, Nave BT (2001) Impaired PI 3-kinase activation in adipocytes from early growth-restricted male rats. Am J Physiol Endocrinol Metab 280: E534-539

Ozanne SE, Olsen GS, Hansen LL, Tingey KJ, Nave BT, Wang CL, Hartil K, Petry CJ, Buckley AJ, Mosthaf-Seedorf L (2003) Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J Endocrinol 177: 235-241

Ozawa T (2001) Ryanodine-sensitive Ca2+ release mechanism in non-excitable cells (Review). Int J Mol Med 7: 21-25